{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T18:12:00Z","timestamp":1795198320035,"version":"4.10.3"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The disease burden of non-melanoma skin cancer (NMSC) has become a significant public health threat. We aimed to conduct a comprehensive analysis to mitigate the health hazards of NMSC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study had three objectives. First, we reported the NMSC-related disease burden globally and for different subgroups (sex, socio-demographic index (SDI), etiology, and countries) in 2019. Second, we examined the temporal trend of the disease burden from 1990 to 2019. Finally, we used the Bayesian age-period-cohort (BAPC) model integrated nested Laplacian approximation to predict the disease burden in the coming 25\u2009years. The Norpred age-period-cohort (APC) model and the Autoregressive Integrated Moving Average (ARIMA) model were used for sensitivity analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The disease burden was significantly higher in males than in females in 2019. The results showed significant differences in disease burden in different SDI regions. The better the socio-economic development, the heavier the disease burden of NMSC. The number of new cases and the ASIR of basal cell carcinoma (BCC) were higher than that of squamous cell carcinoma (SCC) in 2019 globally. However, the number of DALYs and the age-standardized DALYs rate were the opposite. There were statistically significant differences among different countries. The age-standardized incidence rate (ASIR) of NMSC increased from 54.08\/100,000 (95% uncertainty interval (UI): 46.97, 62.08) in 1990 to 79.10\/100,000 (95% UI: 72.29, 86.63) in 2019, with an estimated annual percentage change (EAPC) of 1.78. Other indicators (the number of new cases, the number of deaths, the number of disability-adjusted life years (DALYs), the age-standardized mortality rate (ASMR), and the age-standardized DALYs rate) showed the same trend. Our predictions suggested that the number of new cases, deaths, and DALYs attributable to NMSC would increase by at least 1.5 times from 2020 to 2044.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The disease burden attributable to NMSC will continue to increase or remain stable at high levels. Therefore, relevant policies should be developed to manage NMSC, and measures should be taken to target risk factors and high-risk groups.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12885-022-09940-3","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T22:02:42Z","timestamp":1659218562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":193,"title":["Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25\u2009years"],"prefix":"10.1186","volume":"22","author":[{"given":"Wan","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyu","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengchuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixia","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"issue":"3","key":"9940_CR1","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.soncn.2013.06.002","volume":"29","author":"R Gordon","year":"2013","unstructured":"Gordon R. Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs. 2013;29(3):160\u20139.","journal-title":"Semin Oncol Nurs"},{"issue":"11","key":"9940_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.7748\/ns.31.11.15.s16","volume":"31","author":"L Berry","year":"2016","unstructured":"Berry L. Skin cancer. Nurs Stand. 2016;31(11):15.","journal-title":"Nurs Stand"},{"issue":"3","key":"9940_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/bjd.13258","volume":"171","author":"IM Leigh","year":"2014","unstructured":"Leigh IM. Progress in skin cancer: the U.K. experience. Br J Dermatol. 2014;171(3):443\u20135.","journal-title":"Br J Dermatol"},{"issue":"7","key":"9940_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/14656566.2017.1316372","volume":"18","author":"T Amaral","year":"2017","unstructured":"Amaral T, Garbe C. Non-melanoma skin cancer: new and future synthetic drug treatments. Expert Opin Pharmacother. 2017;18(7):689\u201399.","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"9940_CR5","first-page":"464","volume":"16","author":"N Cheraghi","year":"2017","unstructured":"Cheraghi N, Cognetta A, Goldberg D. Radiation therapy in dermatology: non-melanoma skin Cancer. J Drugs Dermatol. 2017;16(5):464\u20139.","journal-title":"J Drugs Dermatol"},{"key":"9940_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.oraloncology.2019.09.018","volume":"98","author":"B Chua","year":"2019","unstructured":"Chua B, Jackson JE, Lin C, Veness MJ. Radiotherapy for early non-melanoma skin cancer. Oral Oncol. 2019;98:96\u2013101.","journal-title":"Oral Oncol"},{"issue":"3","key":"9940_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.repc.2019.07.008","volume":"39","author":"PM Garrido","year":"2020","unstructured":"Garrido PM, Borges-Costa J. Hydrochlorothiazide treatment and risk of non-melanoma skin cancer: review of the literature. Rev Port Cardiol (Engl Ed). 2020;39(3):163\u201370.","journal-title":"Rev Port Cardiol (Engl Ed)"},{"issue":"4","key":"9940_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/ajd.13025","volume":"60","author":"KB Garbutcheon-Singh","year":"2019","unstructured":"Garbutcheon-Singh KB, Veness MJ. The role of radiotherapy in the management of non-melanoma skin cancer. Australas J Dermatol. 2019;60(4):265\u201372.","journal-title":"Australas J Dermatol"},{"issue":"2","key":"9940_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jaad.2021.03.109","volume":"85","author":"P Aggarwal","year":"2021","unstructured":"Aggarwal P, Knabel P, Fleischer AB Jr. United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019. J Am Acad Dermatol. 2021;85(2):388\u201395.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"9940_CR10","first-page":"283","volume":"11","author":"T Kornek","year":"2013","unstructured":"Kornek T, Augustin M. Skin cancer prevention. J Dtsch Dermatol Ges. 2013;11(4):283\u201396 quiz 297-288.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"10168","key":"9940_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(18)31712-4","volume":"393","author":"J Liang","year":"2019","unstructured":"Liang J, Li X, Kang C, Wang Y, Kulikoff XR, Coates MM, et al. Maternal mortality ratios in 2852 Chinese counties, 1996-2015, and achievement of millennium development goal 5 in China: a subnational analysis of the global burden of disease study 2016. Lancet. 2019;393(10168):241\u201352.","journal-title":"Lancet"},{"issue":"10159","key":"9940_CR12","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(18)32858-7","volume":"392","author":"L The","year":"2018","unstructured":"The L. GBD 2017: a fragile world. Lancet. 2018;392(10159):1683.","journal-title":"Lancet"},{"issue":"3","key":"9940_CR13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/ajd.12751","volume":"59","author":"A Pondicherry","year":"2018","unstructured":"Pondicherry A, Martin R, Meredith I, Rolfe J, Emanuel P, Elwood M. The burden of non-melanoma skin cancers in Auckland, New Zealand. Australas J Dermatol. 2018;59(3):210\u20133.","journal-title":"Australas J Dermatol"},{"issue":"4","key":"9940_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.fsc.2012.07.004","volume":"20","author":"B Cakir","year":"2012","unstructured":"Cakir B, Adamson P, Cingi C. Epidemiology and economic burden of nonmelanoma skin cancer. Facial Plast Surg Clin North Am. 2012;20(4):419\u201322.","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"10159","key":"9940_CR15","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","volume":"392","author":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017","year":"2018","unstructured":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990\u20132017. A systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1923\u201394.","journal-title":"Lancet"},{"issue":"12","key":"9940_CR16","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","volume":"3","author":"T Akinyemiju","year":"2017","unstructured":"Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, et al. The burden of primary liver Cancer and underlying etiologies from 1990 to 2015 at the global, regional, and National Level: results from the global burden of disease study 2015. JAMA Oncol. 2017;3(12):1683\u201391.","journal-title":"JAMA Oncol"},{"key":"9940_CR17","doi-asserted-by":"publisher","first-page":"104485","DOI":"10.1016\/j.oraloncology.2019.104485","volume":"100","author":"S Kansara","year":"2020","unstructured":"Kansara S, Bell D, Weber R. Surgical management of non melanoma skin cancer of the head and neck. Oral Oncol. 2020;100:104485.","journal-title":"Oral Oncol"},{"issue":"11","key":"9940_CR18","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.clon.2019.08.011","volume":"31","author":"C Conforti","year":"2019","unstructured":"Conforti C, Corneli P, Harwood C, Zalaudek I. Evolving role of systemic therapies in non-melanoma skin Cancer. Clin Oncol (R Coll Radiol). 2019;31(11):759\u201368.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"9859","key":"9940_CR19","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/S0140-6736(12)61680-8","volume":"380","author":"JA Salomon","year":"2012","unstructured":"Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, Mokdad A, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the global burden of disease study 2010. Lancet. 2012;380(9859):2129\u201343.","journal-title":"Lancet"},{"issue":"25","key":"9940_CR20","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"key":"9940_CR21","unstructured":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1223\u201349."},{"issue":"2","key":"9940_CR22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12020-021-02692-3","volume":"73","author":"Y Shan","year":"2021","unstructured":"Shan Y, Xu Y, Ye L, Lin X, Chen Y, Miao Q, et al. Socioeconomic disparity in global vision loss burden due to diabetic retinopathy: an analysis on time trends from 1990 to 2017. Endocrine. 2021;73(2):316\u201324.","journal-title":"Endocrine"},{"issue":"2","key":"9940_CR23","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s11357-021-00494-z","volume":"44","author":"A Molassiotis","year":"2022","unstructured":"Molassiotis A, Kwok SWH, Leung AYM, Tyrovolas S. Associations between sociodemographic factors, health spending, disease burden, and life expectancy of older adults (70\u2009+\u2009years old) in 22 countries in the Western Pacific region, 1995-2019: estimates from the global burden of disease (GBD) study 2019. Geroscience. 2022;44(2):925\u201351.","journal-title":"Geroscience"},{"key":"9940_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40364-020-00195-3","volume":"8","author":"Z Du","year":"2020","unstructured":"Du Z, Chen W, Xia Q, Shi O, Chen Q. Trends and projections of kidney cancer incidence at the global and national levels, 1990-2030: a Bayesian age-period-cohort modeling study. Biomark Res. 2020;8:16.","journal-title":"Biomark Res"},{"issue":"17","key":"9940_CR25","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1002\/sim.1481","volume":"22","author":"B M\u00f8ller","year":"2003","unstructured":"M\u00f8ller B, Fekjaer H, Hakulinen T, Sigvaldason H, Storm HH, Talb\u00e4ck M, et al. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med. 2003;22(17):2751\u201366.","journal-title":"Stat Med"},{"issue":"10258","key":"9940_CR26","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(20)30677-2","volume":"396","author":"SE Vollset","year":"2020","unstructured":"Vollset SE, Goren E, Yuan CW, Cao J, Smith AE, Hsiao T, et al. Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the global burden of disease study. Lancet. 2020;396(10258):1285\u2013306.","journal-title":"Lancet"},{"issue":"2","key":"9940_CR27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1684\/ejd.2019.3523","volume":"29","author":"F Sampogna","year":"2019","unstructured":"Sampogna F, Paradisi A, Iemboli ML, Ricci F, Sonego G, Abeni D. Comparison of quality of life between melanoma and non-melanoma skin cancer patients. Eur J Dermatol. 2019;29(2):185\u201391.","journal-title":"Eur J Dermatol"},{"issue":"22","key":"9940_CR28","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.2217\/fon.15.180","volume":"11","author":"X Wu","year":"2015","unstructured":"Wu X, Elkin EE, Marghoob AA. Burden of basal cell carcinoma in USA. Future Oncol. 2015;11(22):2967\u201374.","journal-title":"Future Oncol"},{"issue":"8","key":"9940_CR29","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pi\u00f1eros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941\u201353.","journal-title":"Int J Cancer"},{"key":"9940_CR30","doi-asserted-by":"publisher","first-page":"734354","DOI":"10.3389\/fonc.2021.734354","volume":"11","author":"CJ Stonesifer","year":"2021","unstructured":"Stonesifer CJ, Djavid AR, Grimes JM, Khaleel AE, Soliman YS, Maisel-Campbell A, et al. Immune checkpoint inhibition in non-melanoma skin Cancer: a review of current evidence. Front Oncol. 2021;11:734354.","journal-title":"Front Oncol"},{"issue":"6","key":"9940_CR31","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.brachy.2015.09.001","volume":"14","author":"M Arenas","year":"2015","unstructured":"Arenas M, Argu\u00eds M, D\u00edez-Presa L, Henr\u00edquez I, Murcia-Mej\u00eda M, Gasc\u00f3n M, et al. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment. Brachytherapy. 2015;14(6):859\u201365.","journal-title":"Brachytherapy"},{"issue":"4","key":"9940_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/ajd.12282","volume":"56","author":"E Perera","year":"2015","unstructured":"Perera E, Gnaneswaran N, Staines C, Win AK, Sinclair R. Incidence and prevalence of non-melanoma skin cancer in Australia: a systematic review. Australas J Dermatol. 2015;56(4):258\u201367.","journal-title":"Australas J Dermatol"},{"issue":"2","key":"9940_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jdin.2020.07.001","volume":"1","author":"S Chu","year":"2020","unstructured":"Chu S, Mehrmal S, Uppal P, Giesey RL, Delost ME, Delost GR. Burden of skin disease and associated socioeconomic status in Europe: an ecologic study from the global burden of disease study 2017. JAAD Int. 2020;1(2):95\u2013103.","journal-title":"JAAD Int"},{"issue":"10","key":"9940_CR34","doi-asserted-by":"publisher","first-page":"565","DOI":"10.5694\/mja12.10654","volume":"197","author":"M Fransen","year":"2012","unstructured":"Fransen M, Karahalios A, Sharma N, English DR, Giles GG, Sinclair RD. Non-melanoma skin cancer in Australia. Med J Aust. 2012;197(10):565\u20138.","journal-title":"Med J Aust"},{"issue":"9715","key":"9940_CR35","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0140-6736(09)61196-X","volume":"375","author":"V Madan","year":"2010","unstructured":"Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010;375(9715):673\u201385.","journal-title":"Lancet"},{"issue":"6","key":"9940_CR36","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/aje\/kwt073","volume":"178","author":"S Wu","year":"2013","unstructured":"Wu S, Han J, Li WQ, Li T, Qureshi AA. Basal-cell carcinoma incidence and associated risk factors in U.S. women and men. Am J Epidemiol. 2013;178(6):890\u20137.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"9940_CR37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.14336\/AD.2017.0503","volume":"8","author":"S Garcovich","year":"2017","unstructured":"Garcovich S, Colloca G, Sollena P, Andrea B, Balducci L, Cho WC, et al. Skin Cancer epidemics in the elderly as an emerging issue in geriatric oncology. Aging Dis. 2017;8(5):643\u201361.","journal-title":"Aging Dis"},{"issue":"1","key":"9940_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/phpp.12417","volume":"35","author":"F Larese Filon","year":"2019","unstructured":"Larese Filon F, Buric M, Fluehler C. UV exposure, preventive habits, risk perception, and occupation in NMSC patients: a case-control study in Trieste (NE Italy). Photodermatol Photoimmunol Photomed. 2019;35(1):24\u201330.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"9940_CR39","first-page":"120","volume":"810","author":"U Leiter","year":"2014","unstructured":"Leiter U, Eigentler T, Garbe C. Epidemiology of skin cancer. Adv Exp Med Biol. 2014;810:120\u201340.","journal-title":"Adv Exp Med Biol"},{"key":"9940_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-319-56017-5_3","volume":"996","author":"F Liu-Smith","year":"2017","unstructured":"Liu-Smith F, Jia J, Zheng Y. UV-induced molecular signaling differences in melanoma and non-melanoma skin Cancer. Adv Exp Med Biol. 2017;996:27\u201340.","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 1","key":"9940_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13555-016-0165-y","volume":"7","author":"Z Apalla","year":"2017","unstructured":"Apalla Z, Nashan D, Weller RB, Castellsagu\u00e9 X. Skin Cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches. Dermatol Ther (Heidelb). 2017;7(Suppl 1):5\u201319.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"9940_CR42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1385\/ENDO:25:2:073","volume":"25","author":"J Ren","year":"2004","unstructured":"Ren J, Ceylan-Isik AF. Diabetic cardiomyopathy: do women differ from men? Endocrine. 2004;25(2):73\u201383.","journal-title":"Endocrine"},{"issue":"3","key":"9940_CR43","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s11910-002-0087-1","volume":"2","author":"RR Voskuhl","year":"2002","unstructured":"Voskuhl RR. Gender issues and multiple sclerosis. Curr Neurol Neurosci Rep. 2002;2(3):277\u201386.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"9940_CR44","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/sj.leu.2403756","volume":"19","author":"U Berger","year":"2005","unstructured":"Berger U, Maywald O, Pfirrmann M, Lahaye T, Hochhaus A, Reiter A, et al. Gender aspects in chronic myeloid leukemia: long-term results from randomized studies. Leukemia. 2005;19(6):984\u20139.","journal-title":"Leukemia"},{"issue":"4","key":"9940_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1053\/ctrv.2001.0220","volume":"27","author":"R Molife","year":"2001","unstructured":"Molife R, Lorigan P, MacNeil S. Gender and survival in malignant tumours. Cancer Treat Rev. 2001;27(4):201\u20139.","journal-title":"Cancer Treat Rev"},{"issue":"1\u20133","key":"9940_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S1011-1344(01)00198-1","volume":"63","author":"BK Armstrong","year":"2001","unstructured":"Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001;63(1\u20133):8\u201318.","journal-title":"J Photochem Photobiol B"},{"issue":"1","key":"9940_CR47","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/1097-0215(20010120)95:1<7::AID-IJC1001>3.0.CO;2-X","volume":"95","author":"JA Foote","year":"2001","unstructured":"Foote JA, Harris RB, Giuliano AR, Roe DJ, Moon TE, Cartmel B, et al. Predictors for cutaneous basal- and squamous-cell carcinoma among actinically damaged adults. Int J Cancer. 2001;95(1):7\u201311.","journal-title":"Int J Cancer"},{"issue":"2","key":"9940_CR48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1468-3083.2004.00893.x","volume":"18","author":"J Graells","year":"2004","unstructured":"Graells J. The risk and risk factors of a second non-melanoma skin cancer: a study in a Mediterranean population. J Eur Acad Dermatol Venereol. 2004;18(2):142\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"9940_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1046\/j.1365-2133.2002.04804.x","volume":"147","author":"Y Scrivener","year":"2002","unstructured":"Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol. 2002;147(1):41\u20137.","journal-title":"Br J Dermatol"},{"issue":"1","key":"9940_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"9940_CR51","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/occmed\/kqh098","volume":"54","author":"DJ Gawkrodger","year":"2004","unstructured":"Gawkrodger DJ. Occupational skin cancers. Occup Med (Lond). 2004;54(7):458\u201363.","journal-title":"Occup Med (Lond)"},{"issue":"3","key":"9940_CR52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1742-1241.1998.tb11592.x","volume":"52","author":"JT Lear","year":"1998","unstructured":"Lear JT, Tan BB, Smith AG, Jones PW, Heagerty AH, Strange RC, et al. A comparison of risk factors for malignant melanoma, squamous cell carcinoma and basal cell carcinoma in the UK. Int J Clin Pract. 1998;52(3):145\u20139.","journal-title":"Int J Clin Pract"},{"issue":"7","key":"9940_CR53","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/archderm.135.7.781","volume":"135","author":"A Hannuksela-Svahn","year":"1999","unstructured":"Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol. 1999;135(7):781\u20136.","journal-title":"Arch Dermatol"},{"issue":"5","key":"9940_CR54","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.socscimed.2007.11.035","volume":"66","author":"IM de Kok","year":"2008","unstructured":"de Kok IM, van Lenthe FJ, Avendano M, Louwman M, Coebergh JW, Mackenbach JP. Childhood social class and cancer incidence: results of the globe study. Soc Sci Med. 2008;66(5):1131\u20139.","journal-title":"Soc Sci Med"},{"issue":"6","key":"9940_CR55","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.canep.2010.06.011","volume":"34","author":"M Steding-Jessen","year":"2010","unstructured":"Steding-Jessen M, Birch-Johansen F, Jensen A, Sch\u00fcz J, Kj\u00e6r SK, Dalton SO. Socioeconomic status and non-melanoma skin cancer: a nationwide cohort study of incidence and survival in Denmark. Cancer Epidemiol. 2010;34(6):689\u201395.","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"9940_CR56","doi-asserted-by":"publisher","first-page":"62","DOI":"10.7861\/clinmedicine.16-1-62","volume":"16","author":"LL Griffin","year":"2016","unstructured":"Griffin LL, Ali FR, Lear JT. Non-melanoma skin cancer. Clin Med (Lond). 2016;16(1):62\u20135.","journal-title":"Clin Med (Lond)"},{"issue":"1","key":"9940_CR57","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4161\/derm.24156","volume":"5","author":"J Reichrath","year":"2013","unstructured":"Reichrath J, Reichrath S. The relevance of the vitamin D endocrine system (VDES) for tumorigenesis, prevention, and treatment of non-melanoma skin cancer (NMSC): present concepts and future perspectives. Dermatoendocrinol. 2013;5(1):38\u201350.","journal-title":"Dermatoendocrinol"},{"issue":"6","key":"9940_CR58","doi-asserted-by":"publisher","first-page":"e14340","DOI":"10.1111\/dth.14340","volume":"33","author":"A Durmishi","year":"2020","unstructured":"Durmishi A, Fida M, Hoxha S, Naqo X, Bardhi B, Xhelili M, et al. Are military personnel at a more risk for skin cancers? Dermatol Ther. 2020;33(6):e14340.","journal-title":"Dermatol Ther"},{"issue":"5","key":"9940_CR59","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.3892\/ol.2017.5898","volume":"13","author":"M Rivas","year":"2017","unstructured":"Rivas M, Rojas E, Calaf GM, Barber\u00e1n M, Liberman C, De Paula CM. Association between non-melanoma and melanoma skin cancer rates, vitamin D and latitude. Oncol Lett. 2017;13(5):3787\u201392.","journal-title":"Oncol Lett"},{"key":"9940_CR60","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/978-3-030-92616-8_16","volume":"1367","author":"S Mushtaq","year":"2022","unstructured":"Mushtaq S. The Immunogenetics of non-melanoma skin Cancer. Adv Exp Med Biol. 2022;1367:397\u2013409.","journal-title":"Adv Exp Med Biol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-09940-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-022-09940-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-022-09940-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T04:53:38Z","timestamp":1700888018000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-022-09940-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["9940"],"URL":"https:\/\/doi.org\/10.1186\/s12885-022-09940-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"30 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. Our study is based on open-source data, so there are no ethical issues. All methods are carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"836"}}